Market research
WGS GeneDx Holdings Corp.
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 3B
- P/E ratio
- Not available
- Analyst target
- 90.4444
- Dividend yield
- Not available
- Beta
- 1.98
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- US81663L2007
- Market cap
- 3B
- P/E ratio
- Not available
- Analyst target
- 90.4444
- Dividend yield
- Not available
- Beta
- 1.98
About
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Visit company websiteCommunity
Investor discussion
0 comments
Sign in to join the WGS discussion.
No comments yet
Start a focused discussion about WGS.